We are monitoring the impact of COVID-19 & Recession alarm on APAC Superdisintegrants Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Superdisintegrants Market Research Report – Segmented By Product Type, Application, Therapeutic Area & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2749
Pages: 140

APAC Superdisintegrants Market Size (2022 to 2027)

The size of the Asia Pacific Superdisintegrants Market is expected to grow 106.14 million by 2027 and USD 69.24 million in 2022, growing at a CAGR of 8.92% during the forecast period.

The market for superdisintegrants in the APAC region is expected to be driven by factors such as the increased use of orally disintegrating tablets, rising acceptance of advanced technologies, increased R&D activity, increased R&D investment, and increased adoption rate of innovative drug delivery system technology, the growing generics market, and the development of novel superdisintegrants for the pharmaceutical sector. The considerable increase in the healthcare sector and the pharmaceutical business in these regions account for the majority of this growth. In addition, low-cost manufacturing, rising per capita income, and weak governmental regulation contribute to the superdisintegrants market's rise in the Asia Pacific region.

Increased healthcare spending and awareness are the key drivers driving market development. Disintegrants provide several advantages, including precision dosage, quick action, improved patient compliance, palatability, cost-effectiveness, simplicity of administration, no danger of airway suffocation while swallowing, and versatility in terms of large and small molecules. Ispaghula, gellan gum, fenugreek seed mucilage, and gum karaya, among others, offer several benefits over synthetic superdisintegrants, including biodegradability, chemical inertness, and non-toxicity. In addition, it may be changed in various ways to create different materials for medication delivery systems that aim to improve safety by forming an accessible dosing system.

The shift in pharmaceutical production to emerging markets and the general expansion of the pharmaceutical market in these markets provide considerable market growth opportunities. When solid dosage forms like capsules or tablets are submerged in liquid, superdisintegrants are added to help them dissolve. Because of this advantage, superdisintegrants are widely utilized in the production of disintegrating oral formulations, driving the rising demand for superdisintegrants in the market. Furthermore, patients' growing preference for orally disintegrating tablet (ODT) products will generate attractive market opportunities. Since synthetic superdisintegrants have been the industry standard for decades, further research into natural superdisintegrants will boost the market's future growth.

During the forecast period, safety and quality issues are likely to restrict the growth of the Asia Pacific Superdisintegrants market to some extent. Maintaining safety and satisfying the quality requirements of regulators, end-users, medication makers, and, most crucially, patients and achieving immediate efficiency and maximum transparency in supply chain operations are all challenges that market manufacturers face.

This research report on the APAC Superdisintegrants Market has been segmented and sub-segmented into the following categories:

By Product Type:

  • Natural Superdisintegrants
  • Synthetic Superdisintegrants
    • Modified Starch
    • Crospovidone
    • Modified Cellulose
    • Ion Exchange Resins
    • Calcium Silicates
  • Others

By Application: 

  • Capsules
  • Tablets

By Therapeutic Area: 

  • Gastrointestinal diseases
  • Neurological diseases
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Hematological diseases
  • Inflammatory Diseases

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, China is leading the market while India is in second place. Large populations and rapid medical advancements have assisted the dominance of China in the market. India is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure, and awareness. Growth in the Asia Pacific area is projected to be driven by increased outsourcing of excipients, including superdisintegrants, production of new superdisintegrants, and the widespread usage of sodium starch glycolate orally fast integrating tablets, and adoption of novel technologies (New drug delivery system). However, there is a large market for reasonably priced medical medicines in India and China's fiercely competitive mass marketplaces. Before embarking on new growth initiatives, companies in the superdisintegrants market must take these trends into account. Several large excipient manufacturers are planning capacity expansions at existing facilities in growing markets such as China and India or are establishing new production sites in emerging markets such as China and India.

KEY MARKET PLAYERS:

A few of the notable companies leading the Asia Pacific Superdisintegrants Market covered in this report are Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co., and Huber Corporation.

1.Introduction

                1.1 Market Definition  

                1.2 Study Deliverables

                1.3 Base Currency, Base Year and Forecast Periods        

                1.4 General Study Assumptions 

2. Research Methodology         

                2.1 Introduction             

                2.2 Research Phases    

                                2.2.1 Secondary Research         

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling    

                                2.2.4 Expert Validation

                2.3 Analysis Design       

                2.4 Study Timeline        

3. Overview     

                3.1 Executive Summary 

                3.2 Key Inferences       

                3.3 Epidemology            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)  

                4.1 Market Drivers        

                4.2 Market Restraints  

                4.3 Key Challenges       

                4.4 Current Opportunities in the Market            

5. Market Segmentation            

                5.1 Product Type           

                                5.1.1 Introduction         

                                5.1.2 Natural Superdisintegrants            

                                5.1.3 Synthetic Superdisintegrants        

5.1.3.1 Modified Starch                

5.1.3.2 Crospovidone                    

5.1.3.3 Modified Cellulose                           

5.1.3.4 Ion Exchange Resins                        

5.1.3.5 Calcium Silicates                

                                5.1.4 Others    

                                5.1.5  Y-o-Y Growth Analysis, By Product Type

                                5.1.6  Market Attractiveness Analysis, By Product Type                                 

                                5.1.7  Market Share Analysis, By Product Type

                5.2 Application  

                                5.2.1 Introduction         

                                5.2.2 Capsules

                                5.2.3 Tablets    

                                5.2.4 Y-o-Y Growth Analysis, By Application       

                                5.2.5 Market Attractiveness Analysis, By Application     

                                5.2.6 Market Share Analysis, By Application      

                5.3 Therapeutic Area   

                                5.3.1 Introduction         

                                5.3.2 Gastrointestinal diseases

                                5.3.3 Neurological diseases       

                                5.3.4 Oncology                                 

                                5.3.5 Infectious Diseases           

                                5.3.6 Cardiovascular Diseases  

                                5.3.7 Haematological diseases 

                                5.3.8 Inflammatory Diseases    

                                5.3.9 Y-o-Y Growth Analysis, By Therapeutic Area          

                                5.3.10  Market Attractiveness Analysis, By Therapeutic Area     

                                5.3.11  Market Share Analysis, By Therapeutic Area       

6. Geographical Analysis            

                6.1 Introduction             

                                6.1.1 Regional Trends  

                                6.1.2 Impact Analysis   

                                6.1.3 Y-o-Y Growth Analysis      

6.1.3.1 By Geographical Area                     

6.1.3.2 By Product Type                

6.1.3.3 By Application                    

6.1.3.4 By Therapeutic Area                        

                                6.1.4  Market Attractiveness Analysis   

6.1.4.1 By Geographical Area                     

6.1.4.2 By Product Type                

6.1.4.3 By Application                    

6.1.4.4 By Therapeutic Area                        

                                6.1.5  Market Share Analysis    

6.1.5.1 By Geographical Area                     

6.1.5.2 By Product Type                

6.1.5.3 By Application                    

6.1.5.4 By Therapeutic Area                        

                6.2 China           

                6.3 India            

                6.4 Japan          

                6.5 South Korea             

                6.6 Australia    

7.Strategic Analysis      

                7.1 PESTLE analysis       

                                7.1.1 Political   

                                7.1.2 Economic                                 

                                7.1.3 Social       

                                7.1.4 Technological       

                                7.1.5 Legal        

                                7.1.6 Environmental     

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers      

                                7.2.2 Bargaining Power of Consumers  

                                7.2.3 Threat of New Entrants   

                                7.2.4 Threat of Substitute Products and Services            

                                7.2.5 Competitive Rivalry within the Industry   

8.Market Leaders' Analysis       

                8.1 Ashland      

                                8.1.1 Overview                                 

                                8.1.2 Product Type Analysis      

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments     

                                8.1.5 SWOT analysis     

                                8.1.6 Analyst View        

                8.2 BASF SE      

                8.3 FMC Corporation   

                8.4 JRS Pharma  

                8.5 DFE Pharma 

                8.6 Roquette   

                8.7 The Dow Chemical Company            

                8.8 Asahi Kasei Corporation      

                8.9 Nippon Soda Co.    

                8.10 Huber Corporation 

9.Competitive Landscape          

                9.1 Market share analysis          

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures       

                9.4 New Product Launches       

10.Market Outlook and Investment Opportunities        

Appendix         

                a) List of Tables 

                b) List of Figures            

  1. Asia Pacific Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  2. Asia Pacific Natural Superdisintegrants Market, By Region, From 2022 - 2027 (USD Billion)
  3. Asia Pacific Synthetic Superdisintegrants Market, By Region, From 2022 - 2027 (USD Billion)
  4. Asia Pacific Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  5. Asia Pacific Capsules Market, By Region, From 2022 - 2027 (USD Billion)
  6. Asia Pacific Tablets Market, By Region, From 2022 - 2027 (USD Billion)
  7. Asia Pacific Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  8. Asia Pacific Gastrointestinal Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  9. Asia Pacific Neurological Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  10. Asia Pacific Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  11. Asia Pacific Infectious Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  12. Asia Pacific Cardiovascular Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  13. Asia Pacific Haematological Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  14. Asia Pacific Inflammatory Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  15. Japan Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  16. Japan Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  17. Japan Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  18. China Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  19. China Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  20. China Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  21. India Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  22. India Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  23. India Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  24. Australia Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  25. Australia Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  26. Australia Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  27. South Korea Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  28. South Korea Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  29. South Korea Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  30. Asia Pacific Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  31. Asia Pacific Modified Starch Market, By Region, From 2022 - 2027 (USD Billion)
  32. Asia Pacific Crospovidone Market, By Region, From 2022 - 2027 (USD Billion)
  33. Asia Pacific Modified Cellulose Market, By Region, From 2022 - 2027 (USD Billion)
  34. Asia Pacific Ion Exchange Resins Market, By Region, From 2022 - 2027 (USD Billion)
  35. Asia Pacific Calcium Silicates Market, By Region, From 2022 - 2027 (USD Billion)
  36. Japan Superdisintegrants Market, By Synthetic superdisintegrants, From 2022 - 2027 (USD Billion)
  37. China Superdisintegrants Market, By Synthetic superdisintegrants, From 2022 - 2027 (USD Billion)
  38. India Superdisintegrants Market, By Synthetic superdisintegrants, From 2022 - 2027 (USD Billion)
  39. Australia Superdisintegrants Market, By Synthetic superdisintegrants, From 2022 - 2027 (USD Billion)
  40. Asia Pacific Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  41. Asia Pacific Modified Starch Market, By Region, From 2022 - 2027 (USD Billion)
  42. Asia Pacific Crospovidone Market, By Region, From 2022 - 2027 (USD Billion)
  43. Asia Pacific Modified Cellulose Market, By Region, From 2022 - 2027 (USD Billion)
  44. Asia Pacific Ion Exchange Resins Market, By Region, From 2022 - 2027 (USD Billion)
  45. Asia Pacific Calcium Silicates Market, By Region, From 2022 - 2027 (USD Billion)
  46. Japan Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  47. China Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  48. India Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  49. Australia Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample